ATE289685T1 - Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben - Google Patents

Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben

Info

Publication number
ATE289685T1
ATE289685T1 AT03103218T AT03103218T ATE289685T1 AT E289685 T1 ATE289685 T1 AT E289685T1 AT 03103218 T AT03103218 T AT 03103218T AT 03103218 T AT03103218 T AT 03103218T AT E289685 T1 ATE289685 T1 AT E289685T1
Authority
AT
Austria
Prior art keywords
cervical
solubilized
carcinomas
body sample
overexpression
Prior art date
Application number
AT03103218T
Other languages
English (en)
Inventor
Ruediger Dr Ridder
Anja Dr Reichert
Matthias Dr Herkert
Knebel Doeberitz Magnus Dr Von
Original Assignee
Mtm Lab Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mtm Lab Ag filed Critical Mtm Lab Ag
Application granted granted Critical
Publication of ATE289685T1 publication Critical patent/ATE289685T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
AT03103218T 2003-08-25 2003-08-25 Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben ATE289685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03103218A EP1507148B1 (de) 2003-08-25 2003-08-25 Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben

Publications (1)

Publication Number Publication Date
ATE289685T1 true ATE289685T1 (de) 2005-03-15

Family

ID=33560881

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03103218T ATE289685T1 (de) 2003-08-25 2003-08-25 Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
AT04104026T ATE461449T1 (de) 2003-08-25 2004-08-20 Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04104026T ATE461449T1 (de) 2003-08-25 2004-08-20 Verfahren zum nachweis von medizinisch relevanten zuständen in gelösten lbc-proben

Country Status (13)

Country Link
US (1) US7932047B2 (de)
EP (2) EP1507148B1 (de)
JP (2) JP5619336B2 (de)
CN (1) CN1836166B (de)
AT (2) ATE289685T1 (de)
AU (1) AU2004317284B2 (de)
BR (1) BRPI0414030B8 (de)
CA (1) CA2528490C (de)
DE (2) DE60300339T2 (de)
ES (1) ES2342535T3 (de)
MX (1) MXPA05013903A (de)
RU (1) RU2405158C2 (de)
WO (2) WO2005088311A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
EP1510820B1 (de) * 2003-08-25 2010-03-17 MTM Laboratories AG Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
EP2024520B1 (de) 2006-05-11 2014-03-05 Becton, Dickinson and Company Verfahren zur proteinextraktion aus zellen
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
KR101711860B1 (ko) * 2008-01-25 2017-03-03 베르그 엘엘씨 발암성, 종양 진행 및 치료 효능을 평가하는 분석 시스템
US20090204009A1 (en) * 2008-02-07 2009-08-13 Los Alamos National Security Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue
WO2010025928A1 (en) * 2008-09-04 2010-03-11 Mtm Laboratories Ag Method for prediction of the progression risk of tumors
TWI417389B (zh) * 2008-10-27 2013-12-01 Qiagen Gaithersburg Inc 於自動平台上之快速結果雜交捕捉法
CN101487845B (zh) * 2009-02-19 2013-01-02 苏州海路生物技术有限公司 大便标本自动检测仪
AU2010242867B2 (en) 2009-05-01 2016-05-12 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of RNA splice-forms in a sample
CN102449479B (zh) * 2009-05-07 2015-11-25 安科健康公司 鉴别高度或≥cin2用于人乳头瘤病毒(hpv)与hpv相关癌症的早期及晚期检测、筛检和诊断
JP5819851B2 (ja) * 2010-01-08 2015-11-24 オンコヘルス コーポレーション Ｈｐｖ関連の癌の治療及びスクリーニングのための細胞に基づいた高処理能力ｈｐｖ免疫アッセイ
CA2787781A1 (en) 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Method of determining and confirming the presence of an hpv in a sample
ES2615728T3 (es) 2010-01-29 2017-06-08 Qiagen Gaithersburg, Inc. Métodos y composiciones para una purificación y un análisis múltiple específico de secuencia de ácidos nucleicos
US9422593B2 (en) 2010-05-19 2016-08-23 Qiagen Gaithresburg, Inc Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
CA2799205A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
EP2584046B1 (de) 2010-06-17 2014-11-19 National University Corporation Okayama University Verfahren zum nachweis von durch mikro-rna angezielten genen
GB201014335D0 (en) * 2010-08-27 2010-10-13 Forensic Science Service Ltd Improvements in and relating to analysis
WO2012031273A2 (en) 2010-09-03 2012-03-08 Stem Centrx, Inc. Novel modulators and methods of use
CN102033056B (zh) * 2010-10-14 2012-05-30 中国科学院化学研究所 抑制膜蛋白受体聚集的抗癌药物鉴定方法
AU2012220575B2 (en) 2011-02-24 2017-01-12 Qiagen Gaithersburg, Inc. Materials and methods for detection of HPV nucleic acid
JP6174035B2 (ja) * 2011-11-15 2017-08-02 ユニヴァーシティ・オヴ・マイアミ ヒトパピローマウイルスを検出し頭頸部扁平上皮癌を予後予測する方法
RU2508542C1 (ru) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Экспресс-способ определения риска злокачественности клеток
RU2535071C1 (ru) * 2013-04-09 2014-12-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ диагностики недифференцированной дисплазии соединительной ткани у женщин с потерей беременности в анамнезе
KR102320503B1 (ko) * 2013-07-31 2021-11-03 더 유니버시티 오브 마이애미 대상체에서 암 위험을 동정하는 조성물 및 방법
WO2015147370A1 (en) * 2014-03-28 2015-10-01 Seegene, Inc. Detection of target nucleic acid sequences using different detection temperatures
RU2558987C1 (ru) * 2014-04-21 2015-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ диагностики степени тяжести недифференцированной дисплазии соединительной ткани у женщин репродуктивного возраста
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
WO2016198833A2 (en) 2015-06-08 2016-12-15 Arquer Diagnostics Limited Methods
CN106610434A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术（天津）有限公司 一种hpv16型e7蛋白的elisa检测试剂盒
RU2680930C2 (ru) * 2017-03-24 2019-02-28 федеральное государственное бюджетное образовательное учреждение высшего образования "Северный государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ забора материала для цитологического исследования при опухолевых заболеваниях поджелудочной железы, печени и желчевыводящих путей
CN107748265A (zh) * 2017-09-29 2018-03-02 中南大学湘雅医院 Cdc6和ki67在制备癌症放疗抵抗的诊断标记物中的应用
AU2018397736A1 (en) * 2017-12-29 2020-07-09 Vertex Pharmaceuticals Incorporated Methods of cancer treatment using an ATR inhibitor
US11230729B2 (en) * 2018-04-20 2022-01-25 Inanna Diagnostics, Inc Methods and devices for obtaining cellular and DNA material from human female reproductive system
CN109781977B (zh) * 2019-01-09 2022-03-29 首都医科大学附属北京安定医院 IL15Rα以及相关膜蛋白检测试剂盒及其应用
RU2707099C1 (ru) * 2019-04-24 2019-11-22 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ скрининга злокачественных опухолей органов грудной полости
MX380106B (es) * 2019-05-21 2025-03-12 Timser S A P I De C V Biomarcadores relacionados a cancer.
CN117233382A (zh) * 2023-09-08 2023-12-15 江苏默乐生物科技股份有限公司 一种可同时检测低危型和高危型人乳头瘤病毒的抗原检测试剂盒及其应用
CN119639903B (zh) * 2025-01-17 2025-11-25 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 用于肝内胆管癌的生物标记物、药物及其应用
CN121208346B (zh) * 2025-11-25 2026-04-14 长兴固容生物科技有限公司 一种用于宫颈癌筛查、诊断的标志物组及其用途

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
EP0584264A1 (de) 1991-05-16 1994-03-02 Cold Spring Harbor Laboratory D-typ cyclin und darauf bezogene anwendungen
US5889169A (en) 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
CA2125769C (en) 1991-12-13 1999-01-26 Morgan Van Aken Agglutination assays and kits employing colloidal dyes
US6316208B1 (en) 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
US6060301A (en) 1994-03-18 2000-05-09 Myriad Genetics, Inc. Vector containing MTS1E1β gene
US5989815A (en) 1994-03-18 1999-11-23 University Of Utah Research Foundation Methods for detecting predisposition to cancer at the MTS gene
NZ284612A (en) 1994-03-18 1997-09-22 Univ Utah Res Found Multiple tumour suppressor (mts) gene and its use in the diagnosis and treatment of cancer
CA2164167A1 (en) 1994-12-20 1996-06-21 Izak Bahar Assay normalization method
US6033847A (en) 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5843756A (en) 1995-06-07 1998-12-01 Myriad Genetics, Inc. Mouse MTSI gene
US6403383B1 (en) 1996-03-11 2002-06-11 American Bio Medica Corp. Diagnostic test kit for immunological assays of fluid samples
US5976799A (en) 1996-03-21 1999-11-02 The Board Of Trustees Of The University Of Arkansas Early detection of ovarian carcinoma using P16 gene products
US5955268A (en) * 1996-04-26 1999-09-21 Abbott Laboratories Method and reagent for detecting multiple nucleic acid sequences in a test sample
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
CA2289942C (en) * 1997-05-15 2009-05-05 Thomas Jefferson University Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients
WO1999004238A2 (en) 1997-07-15 1999-01-28 Mitotix, Inc. Reagents and methods for diagnosis and prognosis of proliferative disorders
US6090579A (en) 1997-08-12 2000-07-18 Smithkline Beecham Corporation Human SDR2 cDNA clone
BR9814271A (pt) 1997-12-12 2001-03-20 Digene Corp Determinação de doenças relacionadas com o vìrus do papiloma humano
US20010051364A1 (en) 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
US6686151B1 (en) 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US7399589B2 (en) 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US5994079A (en) 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US6576420B1 (en) 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
DE19829473C2 (de) 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US7306926B2 (en) 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
SE515668C2 (sv) * 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
DE10014685B4 (de) 2000-03-24 2004-07-01 Schubert, Walter, Dr. Verfahren zur Identifizierung von zellspezifischen Zielstrukturen
GB0018140D0 (en) 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
ITRM20010363A1 (it) * 2001-06-25 2001-09-24 Franco Castelmani Gancio adattivo applicato ad un generatore di vivrazioni sinusoidali.
ES2654909T3 (es) * 2002-01-07 2018-02-15 Pretect As Método para detectar ARNm del virus del papiloma humano
EP1333278B1 (de) * 2002-02-01 2004-03-10 MTM molecular tools in medicine Verfahren zur Prognose gastrointestinaler Tumoren
DE60200248T2 (de) 2002-08-01 2005-01-27 Mtm Laboratories Ag Verfahren für Lösung-basierte Diagnose
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases

Also Published As

Publication number Publication date
JP5619336B2 (ja) 2014-11-05
HK1092219A1 (zh) 2007-02-02
WO2005088311A1 (en) 2005-09-22
CN1836166B (zh) 2010-05-26
ES2342535T3 (es) 2010-07-08
ATE461449T1 (de) 2010-04-15
CA2528490A1 (en) 2005-09-22
US20070190529A1 (en) 2007-08-16
JP5677270B2 (ja) 2015-02-25
JP2007503208A (ja) 2007-02-22
DE602004026014D1 (de) 2010-04-29
AU2004317284A1 (en) 2005-09-22
BRPI0414030B8 (pt) 2021-07-27
EP1507148A1 (de) 2005-02-16
BRPI0414030A (pt) 2007-01-23
RU2405158C2 (ru) 2010-11-27
US7932047B2 (en) 2011-04-26
DE60300339D1 (de) 2005-03-31
CA2528490C (en) 2015-11-03
EP1664788A1 (de) 2006-06-07
CN1836166A (zh) 2006-09-20
EP1507148B1 (de) 2005-02-23
AU2004317284B2 (en) 2009-11-05
WO2005084103A2 (en) 2005-09-15
JP2012032412A (ja) 2012-02-16
DE60300339T2 (de) 2006-04-13
MXPA05013903A (es) 2006-03-09
RU2006101395A (ru) 2006-06-10
BRPI0414030B1 (pt) 2017-04-04

Similar Documents

Publication Publication Date Title
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
PH12020551371A1 (en) Assays to detect neurodegeneration
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
MY145455A (en) Diagnostic biomolecule(s)
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
ATA19972000A (de) Pibf für die diagnose von tumoren
EA201001340A1 (ru) Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome
TW200502399A (en) Recombinant virus and use thereof and method of detecting an analyte in a sample and kit thereof
WO2005040807A3 (en) Swiprosin-2 as a breast cancer marker
SG152020A1 (en) Diagnostic methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties